Multiplex in situ hybridization within a single transcript: RNAscope reveals dystrophin mRNA dynamics by Hildyard, J C W et al.
RESEARCH ARTICLE
Multiplex in situ hybridization within a single
transcript: RNAscope reveals dystrophin
mRNA dynamics
John C. W. HildyardID
1, Faye Rawson1, Dominic J. Wells2, Richard J. Piercy1
1 Comparative Neuromuscular Diseases Laboratory, Department of Clinical Science and Services, Royal
Veterinary College, London, United Kingdom, 2 Department of Comparative Biomedical Sciences, Royal
Veterinary College, London, United Kingdom
* jhildyard@rvc.ac.uk
Abstract
Dystrophin plays a vital role in maintaining muscle health, yet low mRNA expression,
lengthy transcription time and the limitations of traditional in-situ hybridization (ISH) me-
thodologies mean that the dynamics of dystrophin transcription remain poorly understood.
RNAscope is highly sensitive ISH method that can be multiplexed, allowing detection of indi-
vidual transcript molecules at sub-cellular resolution, with different target mRNAs assigned
to distinct fluorophores. We instead multiplex within a single transcript, using probes tar-
geted to the 5’ and 3’ regions of muscle dystrophin mRNA. Our approach shows this method
can reveal transcriptional dynamics in health and disease, resolving both nascent myonuc-
lear transcripts and exported mature mRNAs in quantitative fashion (with the latter absent in
dystrophic muscle, yet restored following therapeutic intervention). We show that even in
healthy muscle, immature dystrophin mRNA predominates (60–80% of total), with the sur-
prising implication that the half-life of a mature transcript is markedly shorter than the time
invested in transcription: at the transcript level, supply may exceed demand. Our findings
provide unique spatiotemporal insight into the behaviour of this long transcript (with implica-
tions for therapeutic approaches), and further suggest this modified multiplex ISH approach
is well-suited to long genes, offering a highly tractable means to reveal complex transcrip-
tional dynamics.
Introduction
The dystrophin gene is the largest in the genome: at approximately 2.4Mbp in length this single
gene accounts for almost 0.1% of human haploid DNA and occupies fully 1.5% of the X chro-
mosome where it resides. Transcription of a single full-length 79-exon dystrophin mRNA is
estimated to take 16 hours, with translation giving rise to dp427 dystrophin (a protein product
of 427kDa). This lengthy gene also displays unconventional transcriptional behaviour: the
dp427 transcript can arise from three separate promoters controlling cortex, muscle and Pur-
kinje cell expression, producing dp427c, dp427m and dp427p respectively [1, 2]. Each pro-
moter confers a unique first exon but the other 78 are shared, resulting in dp427 proteins
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essentially identical in sequence, differing only in the first 3–11 amino acids (of a total of
almost 3700). The dystrophin gene also carries several internal promoters producing shorter
transcripts, generating multiple N-terminally truncated protein isoforms (similarly named by
molecular weight, thus dp260 [3], dp140 [4], dp116 [5], and dp71 [6]): see Fig 1A. These iso-
forms show clear tissue-specific expression patterns and likely play unique cellular roles, but
most studies to date have focussed on dp427m, the full-length muscle isoform: mutations
almost anywhere in the dystrophin gene affect this isoform, and this isoform is critical to
human health.
Dp427m is the only dystrophin isoform canonically expressed in skeletal muscle [7], and
the long dp427 protein it encodes contains three principal domains: an N-terminal actin-bind-
ing region, a C-terminal dystroglycan-binding region, and a lengthy ‘rod’ domain of 24 spec-
trin-like repeats linking the two (Fig 1B) [8]. This protein localizes to the sarcolemma (Fig 1C)
where it forms a key component of the dystrophin-associated glycoprotein complex (DAGC),
co-localizing proteins that aid muscle function such as neuronal nitric oxide synthase (nNOS)
[9] and acting as a physical link between the intracellular actin cytoskeleton and the extracellu-
lar matrix environment [10]. Insufficient or absent muscle dp427 (Fig 1D) results in weakness
of the muscle sarcolemma, leaving muscle fibres vulnerable to contraction-induced injury,
leading to the incurable and fatal muscle-wasting disease, Duchenne muscular dystrophy
(DMD). This X-linked disease, affecting 1 in 5000 new born boys [11, 12], is characterized by
cycles of muscle degeneration and compensatory regeneration, with concomitant persistent
inflammation and progressive loss of muscle tissue to fat and fibrotic scarring: boys become
wheelchair-bound between the age of 8 and 12, and death typically occurs in the 20s-30s via
either cardiac or respiratory failure [13]. Mutations that cause premature termination of
dp427 result in DMD, however mutations that cause in-frame internal truncation of dp427
typically lead to the milder condition, Becker muscular dystrophy (BMD), suggesting that
while N and C termini are critical for function, the rod domain is largely dispensable: indeed,
use of antisense oligonucleotides to mask splicing sites in the dp427 pre-mRNA leads to omis-
sion of targeted exons in DMD-causing transcripts and consequent restoration of reading
frame, offering a means to change DMD to a BMD phenotype. These ‘exon-skipping’
approaches represent a promising therapeutic approach.
Dystrophin remains a challenging target of investigation: dp427 represents only a tiny frac-
tion of total muscle protein (~0.002% [14]), and levels of transcripts within skeletal muscle are
Fig 1. Dystrophin mRNA isoforms and full-length protein. (A) Cortical, muscle and Purkinje isoforms of full length
dystrophin (dp427) have unique first exons but share all 78 downstream exons. Dp260 shares all sequence from exon 30,
dp140 from exon 45, dp116 from exon 56 and dp71 from exon 63. Target sequence regions of the 5’ and 3’ probes used in this
study are shown (green and magenta bars): 5’ probe recognizes dp427 only (c, m and p), while 3’ probe will recognize all
dystrophin isoforms. (B) dp427 protein has three principal domains: N-terminal actin binding, spectrin repeat rod domain,
and C-terminal dystroglycan binding. Skeletal muscle dystrophin protein localizes to the sarcolemma in healthy mouse
quadriceps muscle (C) but is absent in dystrophic mdx quadriceps muscle (D). Scale bar: 200!m (subdivisions: 40!m).
https://doi.org/10.1371/journal.pone.0239467.g001
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consequently similarly modest [15, 16]. Immunohistochemistry with specific antibodies allows
the subcellular localization of dystrophin protein to be determined with high accuracy, but
similar studies at the mRNA level are more challenging. In-situ hybridization (ISH) with bioti-
nylated [17] or radiolabelled [18] probes suggests a sarcolemmal localization of the dp427 tran-
script, but further details are confounded by the innate limitations of this technique and the
low transcript abundance. Most studies of dp427 mRNA dynamics have therefore typically
measured dystrophin expression in whole muscle extracts, necessarily discarding spatial infor-
mation. As muscle tissue is host to multiple cell types [19], such approaches also introduce
unavoidable noise (a problem exacerbated in dystrophic muscle where infiltrating inflamma-
tory cells, fibroblasts, adipocytes and differentiating myoblasts further diversify the cellular
milieu [20]). Despite these limitations, pioneering work by Tennyson et al [21] determined
estimates for dp427 transcription time of the order of 16 hours, and showed that splicing
occurred co-transcriptionally (work subsequently supported by others investigating transcrip-
tion of long genes [22] where co-transcriptional splicing and elongation rates of 40–60 bases
per second were reported). Further investigations [16] suggested that in human muscle dp427
5’ sequence was present in excess of 3’ sequence (i.e. nascent transcripts exceeded mature),
suggesting the half-life of mature dp427 might be modest, but at the time such work necessi-
tated transcript estimation via somewhat crude RT-PCR autoradiography. An elegant recent
study by Gazzoli et al revealed that co-transcriptional splicing of dp427 occurs non-sequen-
tially, and that long introns in particular (several are >100kb) are spliced in multiple steps
[23], however most studies of dp427 focus on disease- or therapeutic-relevant metrics such as
the efficiency of exon-skipping (percentage of skipped transcripts) rather than more general
properties of the mRNA itself. Recent technological advances such as RNAscope [24] have led
to a resurgence in ISH-based investigations, suggesting that detailed study of muscle dp427
mRNA at the histological level might now be practical and (given the large size and low abun-
dance of the transcript, and the unique multinucleate nature of myofibres) also highly
nuanced.
RNAscope ISH employs proprietary ‘ZZ’ oligonucleotide probe pairs: each probe carries
~25 bases of target-complementary sequence linked to one half of a preamplifier-binding
motif. The preamplifier carries multiple amplifier-binding motifs, and the amplifiers in turn
are able to bind peroxidase enzymes in very high local concentrations. Use of 20 such ZZ pairs
in series allows targeting of ~1000 bases of target sequence (rendering this method highly spe-
cific), and use of the amplification strategy with peroxidase-activated tyramide dyes affords
very high sensitivity, allowing detection of individual mRNA transcripts with sub-cellular reso-
lution (Fig 2A–2E). Crucially, this technique can also be multiplexed: by use of probe-specific
amplifiers and sequential labelling, multiple mRNA species can be resolved, each with a differ-
ent fluorophore (Fig 2F). We reasoned that this approach might be further refined: at 14kb, a
full-length dystrophin transcript should permit multiple 20ZZ probe sets to bind simulta-
neously (a hypothesis supported by Smith et al, using conventional fluorescent probes [25] to
resolve nascent transcriptional loci within cultured myonuclei). We have previously confirmed
the validity of this approach, using a triplex strategy (targeting 5’, middle and 3’ sequence of
the dp427 transcript) to reveal expression of different dystrophin isoforms in the developing
embryo [26]: dp427 transcripts in nascent muscle were labelled with all three probes, dp140
transcripts in the developing brain were labelled with only middle and 3’, while cell types
known to be rich in the short dp71 isoform (such as epithelia) labelled with the 3’ probe alone.
Here we study mature skeletal muscle, a tissue known to express only full-length muscle
dystrophin (dp427m). Given the ~16 hour transcription time of this long mRNA, use of probes
to 5’ and 3’ sequence of dp427 (see Fig 1A) offers an elegant means to label transcripts in a
temporal fashion, in a manner similar to that first used by Garcia et al [27], but without
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recourse to complex transgenics. This approach should allow detection of individual mature
and nascent dystrophin mRNA molecules within skeletal muscle: the majority of nascent tran-
scripts would bind 5’ only, while mature would bind both (Fig 2G). We have used these probes
in healthy wild-type (WT) and dystrophic (mdx) mouse muscle, and in mdx muscle rescued
with exon-skipping agents, to gain insights into the localization and dynamics of this critical
transcript in health and disease. Our work supports the findings of previous investigations
while adding spatiotemporal refinements unachievable by other means, offering a powerful




20ZZ RNAscope probes (ACDBio) were designed to mouse dystrophin sequence (accession
number NM_007868.6). The catalogue probe (Mm-Dmd, Cat. No. 452801) recognizes resi-
dues 320–1295 (exons 2 to 10) of the full-length (dp427) dystrophin transcript. This probe
(henceforth: 5’ probe) recognizes full-length dp427 only, but will bind both nascent and mature
Fig 2. RNAscope ISH method. (A) RNAscope ZZ probe pairs bind 30–50 bases of target sequence. Adjacent probes
create a target motif for preamplifier molecules (B), which bind amplifiers, which bind probe-specific enzyme to
deposit high local concentrations of fluorophore (C). Off-target effects are minimized as both elements of the ZZ pair
must bind in close proximity. A single Z probe is insufficient to bind preamplifier (E). Probe sets of 20 sequential ZZ
pairs (F) can be used to ensure high specificity, and sequential probe-specific dye-labelling allows different
fluorophores to label different mRNA target molecules. (G) dp427 can be targeted with multiple probes: sets targeting
5’ (exons 2–10) and 3’ (exons 64–75) regions of dp427 permit distinction of nascent (5’ only) and mature (5’ and 3’)
transcripts.
https://doi.org/10.1371/journal.pone.0239467.g002
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dp427 transcripts. A further custom probe (Mm-Dmd-O1, henceforth: 3’ probe) was designed
to residues 9581–10846 (exons 64–75). This 3’ probe hybridizes to sequence emerging late in
transcription, favouring mature transcripts. Given shared sequence, 3’ probe will recognize
essentially all dystrophin isoforms (dp427, 260, 140, 116, 71 –see Fig 1A).
Positive control probes to POLR2A (NM_009089.2, residues 2802–3678), PPIB
(NM_011149.2, residues 98–856) and UBC (NM_019639.4, residues 36–860) were used to
confirm preservation of sample RNA, while negative control probes to bacterial DapB
(EF191515, residues 414–862) were used to establish non-specific labelling.
Ethics statement
A total of ten male mice were used in this study (6 mdx and 4 wild-type C57BL/6J). All mice
were bred under UK Home Office Project Licence PPL 70/7777 (holder Professor Dominic
Wells), approved by the Royal Veterinary College Animal Welfare and Ethical Review Body.
Mice were held in open top cages in a minimal disease unit at an average 21˚C in a 12 hours
light/ 12 hours dark light cycle with food and water provided ad-lib. Seven 40-week old male
mice (3 mdx, 4 wild-type–referred to within the text as mdx 1–3 and WT 1–4) were collected
specifically for this study, while a further three 32-week old male mdx mice (untreated–mdx 4
within the text-, or treated intravenously with PIP6a peptide-conjugated antisense morpholino
oligonucleotide (PPMO) at 6mg.kg-1 and 12.5mg.kg-1) were archive samples taken from two
separate studies ([28] and manuscript in preparation): briefly, mice were treated via tail vein
injection with the PPMO starting at 12 weeks of age, continuing for a total of 10 injections
each separated by two weeks with collection two weeks after the last dose. All animals were
killed by cervical dislocation, with tissues harvested rapidly post mortem. Quadriceps cDNA
samples used for qPCR analysis (9 mdx, 9 WT) were archive samples from our collection and
were not prepared specifically for this study.
Sample preparation and cryosectioning
Quadriceps muscles used for this study were mounted longitudinally (a configuration that
generates longitudinal and transverse regions within a single section) in cryoMbed mounting
medium (Bright instruments Ltd) and flash-frozen in liquid N2-cooled isopentane. Freezing in
an essentially relaxed configuration rather than pinned out to L0 reduces fibre hypercontrac-
tion immediately post-sectioning (see below). Muscle tissues were sectioned at -25˚C to 8!m
thickness using an OTF5000 cryostat (Bright) and mounted on glass slides (SuperFrost,
VWR). Preparation of longitudinal sections from frozen mouse muscle is non-trivial: transient
melting during transfer of section to slide typically results in considerable fibre hypercontrac-
tion as contractile proteins respond to abundant free calcium ions. RNAscope ISH involves
multiple detergent washes and incubations at 40˚C, necessitating the enhanced tissue affinity
of SuperFrost slides, but this slide format is incompatible with EDTA-coating methods of
Pearson and Sabarra [29]. It was determined that freezing muscles in a relaxed state and sec-
tioning at 8 micron thickness generates acceptable longitudinal sections without the require-
ment for EDTA: at this thickness, shear forces generated by contractile proteins in the
presence of free Ca2+ appear largely insufficient to overcome the rapid adhesion to SuperFrost
slides. Serial sections were collected and slides were air-dried at -20˚C for 1 hour before storage
at -80˚C until use.
Staining
Immunofluorescence. Slides were allowed to equilibrate to room temperature, blocked
for 1hr using 5% milk powder (Marvel) in PBS + 0.05% tween (PBS-T), and then co-
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immunolabelled with rabbit polyclonal anti-dystrophin (ab15277, Abcam, 1:800) and rat
monoclonal anti-perlecan (clone A7L6, Thermofisher, 1:2000), in PBS-T for 1hr. Secondary
labelling used Alexa-fluor conjugated antibodies (anti-rabbit 488 and anti-rat 594 respectively,
Thermofisher, both 1:1000, 1hr). Nuclei were stained using Hoechst 33342 (Thermofisher,
1:2000, 10 minutes), and slides were then washed and mounted using Hydromount (National
Diagnostics).
Succinate dehydrogenase. Slides were allowed to equilibrate as above, then incubated
with freshly-prepared SDH staining solution (125mM sodium succinate, 1.5mM nitroblue tet-
razolium, 60mM Tris HCL, pH 7.0) at 37˚C for 1 hour, fixed in formal calcium for 15mins at
room temperature, then washed and mounted in Hydromount.
RNAscope slide preparation
The combination of protease digestion and detergent-rich wash buffer used by RNAscope is
incompatible with fresh-frozen muscle prepared according to standard protocols: while con-
nective tissue/extracellular matrix elements (and most nuclei) were readily retained through-
out the protocol, myofibrillar content was rapidly lost leaving empty myofibre ‘ghosts’ (see S1
Fig). Preparation of frozen muscle thus required extended fixation and an additional baking
step (both indicated with an asterisk): slides were removed from -80˚C storage and placed
immediately into cold (4˚C) 10% neutral-buffered formalin, then incubated at 4˚C for 1 hour⇤.
Slides were then dehydrated in graded ethanols (50%, 70%, 100% x2, 5mins in each, room tem-
perature) and left in 100% ethanol at -20˚C overnight, then air-dried and baked at 37˚C for 1
hour⇤. Sections were ringed using hydrophobic barrier pen (Immedge, Vector Labs) and then
treated with RNAscope hydrogen peroxide (ACDbio) for 15mins at room temperature to
quench endogenous peroxidase activity. After washing twice in PBS, slides were protease-
treated (RNAscope Protease IV, ACDbio) for 30mins at room temperature and washed a fur-
ther two times in PBS before use in RNAscope multiplex assay (see below).
RNAscope multiplex assay
Multiplex assays were performed according to the manufacturer’s protocols. All incubations
were at 40˚C and used a humidity control chamber (HybEZ oven, ACDbio). Probe mixes used
were as follows:
• RNAscope 3-plex positive control probe set (320881): POLR2A, PPIB and UBC (low, mod-
erate and high expression targets supplied as C1, C2 and C3 probes, respectively)
• RNAscope 3-plex negative control probe set (320871): Bacterial DapB (in C1, C2 and C3
probe sets)
• RNAscope mouse dystrophin probe set: Mm-Dmd (452801) and Mm-Dmd-O1 (custom
probe) (C1 and C2 probes, targeting 5’ and 3’ sequence respectively).
Tyramide dye fluorophores (FITC, Cy3, Cy5: TSA plus, Perkin Elmer NEL760001KT) were
used diluted appropriately in RNAscope TSA dilution buffer. Nuclei were labelled with RNA-
scope DAPI (ACDbio) for 30 seconds, or Hoechst (1/2000 in wash buffer for 10mins followed
by two washes). Slides were mounted in Prolong Gold Antifade mounting medium
(Thermofisher).
Positive and negative control slides were typically given the following fluorophore assign-
ments: C1 –TSA-FITC; C2 –TSA-Cy3; C3 –TSA-Cy5. Due to weak FITC fluorescence and
strong signal intensity of the 5’ dystrophin probe (as compared with the 3’ probe), many com-
binations of fluorophore posed either poor probe comparability or signal bleed-through
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PLOS ONE | https://doi.org/10.1371/journal.pone.0239467 September 24, 2020 6 / 29
(particularly those using TX2 filter cubes). Our preferred final fluorophore combination for
dystrophin was therefore TSA-Cy3 and TSA-Cy5 (for C1 5’ and C2 3’, or switched as indi-
cated). Used with the N3 and Y5 filter cubes, this combination of fluorophores had no signal
overlap and allowed selection of modest exposure times without bleed-through. TSA dyes
were used at the following dilutions: TSA-FITC, 1/500; TSA-Cy3, 1/1500; TSA-Cy5, 1/750.
Imaging
Individual images were collected using either a DM4000B or DMRA2 upright fluorescence
microscope with samples illuminated using an EBQ100 light source and A4, L5, N3 and Y5⇤
filter cubes (Leica Microsystems) and an AxioCam MRm monochrome camera controlled
through Axiovision software version 4.8.2 (Carl Zeiss Ltd). For all analysis, images were cap-
tured via 20x objectives (20x HC PL FLUOTAR PH2, NA = 0.5) which readily enabled identifi-
cation of discrete foci corresponding to individual transcripts, while retaining sufficient axial
resolution to allow all elements of the tissue section to remain well-focussed. Multiple images
(9–30) were collected per muscle section, selected randomly (avoiding section tears and tendi-
nous regions). For particle counts, exposure times were calculated to allow clear detection of
small foci in all channels (typically 600-1500msec). For fluorescence intensity (3–5 images per
muscle section), multiple exposure times were collected (100-1000msec) to minimize risk of
signal saturation. For whole section alignments, images were collected at 5x and stitched using
the pairwise-stitching algorithm of Preibisch et al [30]. After analysis, images shown in figures
were adjusted for clarity using the window/level tool (imageJ).
Image analysis
Collected images (as tiff format files) were analysed using the Fiji distribution of ImageJ, using
automated macros (all requisite.ijm files can be found at the figshare repository at the follow-
ing DOI: 10.6084/m9.figshare.9764930). In brief, images were separated into Cy5, Cy3 and
DAPI channels: for counts of nuclei, nuclear stain was thresholded automatically using either
Huang or Yen’s algorithm [31] and given a single binary watershed pass to separate adjacent
nuclei. Cy3 and Cy5 channels were thresholded to eliminate background/non-specific staining
and foci were counted using the ‘Analyze Particles’ tool. Fluorescence microscopy cannot
reveal the true size of fluorescent particles (instead resolving a point-spread function [32]) but
apparent size allows discriminatory analysis: apparent particle areas were converted to square
microns using the appropriate multiplier for the magnification and image resolution. For
nuclear/extranuclear particle analysis, the DAPI channel was thresholded as above and applied
as a mask to the Cy3/Cy5 channels (eliminating nuclear-localized signal) or applied as an
inverted mask (eliminating non-nuclear signal) prior to thresholding and particle counting.
Nearest neighbour analysis used extranuclear foci only, with analysis then repeated using the
same images with the 3’ channel rotated by 90 degrees (distributions for random points were
obtained from the average of ~1000 virtual fields of randomly-generated points of specified
total number). For 5’ probe fluorescence intensity analysis (due to stark differences in 5’ signal
intensity) 3–5 images per animal were collected at multiple exposure times (see above): regions
of interest (sharply-defined small foci, broad nuclear probe signals, and background regions;
30–50 per image, 10–15 for background) were determined from the highest exposure, then
quantified at lower exposure times using only non-saturated signal.
Calculations
Mean values of transcripts per field were used to calculate total transcript numbers via the fol-
lowing calculations: 1388x1040 pixel imaging field at 20x (~2 pixels per micron) = 360880!m2
PLOS ONE RNAscope reveals dystrophin mRNA dynamics
PLOS ONE | https://doi.org/10.1371/journal.pone.0239467 September 24, 2020 7 / 29
at a section thickness of 8um, thus 2889040!m3 (2.9x10-3mm3). At a muscle density of 1.06g.
ml-1 [33], a single imaging field thus represents ~3!g of tissue. Typical RNA yields per mg of
muscle tissue are 0.25–0.5!g, thus a single 20x imaging field can be considered to contain
0.75–1.5ng of total RNA.
Calculation of transcript half-lives. Half-life calculations used the method provided by
Tennyson and colleagues [16]. At steady-state, the ratio of 5’ sequence (nascent and mature








The half-life of a given species is related to the mean lifetime by the equation Tlifetime = T1/2/0.693.
Our 5’ probe sequence ends at exon 10 and the 3’ at exon 74 (1550kbp between the two)
while our qPCR regions (see below) were designed to the exon 1:2 and exon 62:63 boundaries
(1950kbp); assuming 16 hour constant-rate transcription for full-length dp427 [21] this gives
an approximate transcription time between 5’ and 3’ of ~11 hours for RNAscope probe regions
and 13.5 hours for qPCR amplicon regions.
RNA isolation and qPCR
cDNAs used for qPCR (male quadriceps muscle, 9 WT, 9 mdx) were archive samples from our
collection. Isolation and preparation methods were as described previously [34, 35]: RNA was
isolated from muscle powder (homogenized under liquid nitrogen) using TRIzol reagent
(Invitrogen) with inclusion of an additional chloroform extraction (1:1) after phase separation.
RNA was assessed to determine yield and purity (nanodrop ND1000) and used to prepare
cDNA via RTnanoscript2 (Primerdesign). Triplicate qPCRs used 10!l volumes (~8ng cDNA
per well assuming 1:1 conversion) in a CFX384 lightcycler using PrecisionPLUS SYBR green
qPCR mastermix (Primerdesign), with a melt curve included as standard. Primers to ACTB,
RPL13a, CSNK2A2 and AP3D1 (reference genes determined previously [34]) were taken from
the geNorm and geNorm PLUS kits (Primerdesign). Primers to dystrophin dp427 and dp71
were designed using primer3 software (http://primer3.ut.ee/) and all span one or more introns
(exons 62 and 63 are very short -61 and 62bp respectively- thus the reverse primer for this
amplicon lies in exon 64, consequently spanning intron 62 and 63). All primer sets gave PCR
efficiencies of 90–105% and all produced a single amplicon. Absolute quantification of tran-
script numbers was performed via standard curve (dilution series of purified, quantified PCR
products from 10^7 molecules per well down to 10^-2), allowing accurate measurement of
transcript numbers down to ~10–100 molecules.well-1 (typical values from muscle cDNAs
were 500–50000 transcripts.well-1).
Dp427m Exon1 Fwd ¶7&7&$7&*7$&&7$$*&&7&&¶
Dp427 Exon2 Rev ¶*$**&*7777&&$7&&7*&¶
Dp427 exon44 Fwd ¶7**&7*$$7*$$*77*$$&$*7¶
Dp427 exon45 Rev ¶&&*&$*$&7&$$*&77&&7$¶
Dp427 exon62 Fwd ¶$*&&$7&7&$&&$$$&$$$*7¶
Dp427 exon64 Rev ¶$&*&**$*$$&&7*$&$77$¶
Dp71 exon1 Fwd ¶*7*$$$&&&77$&$$&&$7*$*¶
Dp71 exon2 Rev ¶&77&7**$*&&77&7*$*&¶
Statistical analysis
Statistical analyses of nuclear counts and fluorescent foci counts used two-tailed Mann-Whit-
ney U tests, while correlation analysis (5’ vs 3’ foci, total foci vs SDH or nuclear count) used
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Pearson r or Spearman’s rho as appropriate (indicated). Significance was set at P<0.05. To
confirm adequate sample size for fluorescence intensity analysis, values for small 5’ foci
(means, standard deviations) obtained from three WT mice were analysed using the post-hoc
methods of Snedecor and Cochrane [36]. 70–80 foci are necessary to determine the mean with
precision of ±10% at 95% confidence: numbers of measured foci (84–112 per individual) are
sufficient in all cases. All statistical analyses were conducted using Graphpad Prism 7 and
Microsoft Excel.
Results
Multiplex ISH to 5’ and 3’ regions of dp427 allows detection of nascent and
mature transcripts
RNAscope in-situ labelling allows resolution of individual mRNA molecules, particularly
when used with low-abundance transcripts [24], and the expected staining pattern is that of
small, punctate foci with an apparent diameter of 1–1.5!m distributed throughout the cell inte-
rior. Muscle labelled with positive control probes (to Polr2a, Ppib and UBC: very low, low and
high-expression in skeletal muscle, respectively [37]) behaved consistently with these expecta-
tions (S2A and S2B Fig). Negative control probes (bacterial DapB in all channels) produced no
foci (S2C and S2D Fig), though diffuse, weakly-stained signal was found within small patches
of cells in all dystrophic tissues, with all fluorophores. These were also observed in dystrophic
positive control slides, but not in healthy muscle (see S2 Fig, arrowheads) and most likely rep-
resent aberrant tyramide dye deposition within infiltrating macrophages (these cells are com-
mon to dystrophic tissue, and are rich in endogenous peroxidases that might not be fully
quenched). In contrast, muscle labelled with RNAscope probes to dystrophin 5’ and 3’
sequence revealed a striking and highly probe-specific distribution of signal. In healthy muscle
(Fig 3) 5’ probe signal fell into two separable categories: the expected population of small,
punctate foci distributed along the entire body of the myofiber (with the highest concentra-
tions found closest to the sarcolemma), but also a second, less-numerous population of broad,
heterogeneous and high-intensity signals localized exclusively to specific nuclei. The intensity
of this latter population was such that these large 5’ foci were readily detectable even at low
magnification. 3’ probe signal displayed essentially only the former punctate signal, both
within nuclei and without; notably, these foci were typically found adjacent to 5’ foci. These
distributions were consistent throughout the entire muscle section, both in transverse and lon-
gitudinal fibres, and reciprocal patterns were observed if the fluorophores chosen were
exchanged (i.e. signal intensity and localization is a property of the probes alone: S3 Fig).
The genomic sequence of the dp427 region targeted by our 5’ probe (exons 2–10) begins
~190kb downstream from dp427m exon 1 and spans ~525kbp: assuming a constant,
sequence-independent transcription rate of ~40bases.sec-1 with concurrent splicing (suggested
by the 16-hour transcription time for a 2.3Mb gene, and supported by studies of other long
genes [21, 22]), the first nucleotides of this sequence should emerge ~1.3 hours after initiation,
with the full 20ZZ probe-binding region being completed ~3.5 hours later and persisting
within the nucleus for a further ~11 hours. In contrast, 3’ probe sequence (exons 64–75) begins
2.1 megabases downstream of exon 1 and concludes a mere ~88kb later, only 28kb from the
transcription termination site. Under the assumptions above, full 3’ probe sequence emerges
less than 15 minutes before transcript completion, and subsequent nuclear export of com-
pleted mRNA is likely to be rapid [38] (especially compared to dp427 transcription time).
Consistent with this, nuclear staining for 5’ sequence (but not 3’) demonstrates our
approach can detect nascent dp427 transcripts. The intensity of nuclear 5’ labelling further
implies that multiple nascent transcripts are present within any given nucleus: myonuclear
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commitment to dp427 expression might be concerted. Smaller foci (both 5’ and 3’) found out-
side nuclei should thus correspond to dual-labelling of mature, exported dp427 transcripts. Sup-
porting this, labelling of dystrophic mdx muscle with our probes (Fig 4) revealed key differences
to healthy muscle: prominent 5’ nuclear foci were readily detected, including within centrally-
located nuclei characteristic of regenerated mdx muscle (see left side of Fig 4B), but smaller
punctate foci from both probe sets appeared greatly reduced in number, and were almost exclu-
sively found within (or adjacent to) nuclei. Additionally, dystrophic muscle also exhibited rare
nuclei associated with multiple 3’ foci alone (Fig 4B, Arrows), a labelling pattern consistent with
expression of the short dystrophin isoform dp71 (as we have shown previously [26]).
The well-defined ISH foci produced by low-abundance transcripts are amenable to quanti-
tative image analysis, allowing measurement of both particle number and apparent area. Con-
firming our observations above, healthy muscle particle counts were significantly higher than
those for dystrophic muscle for both 5’ and 3’ probes (Fig 5A and Table 1): 600–1400 small
foci (of either probe) were found in every WT muscle image, compared with only 100–300 in
mdx. Per-image variation was however notable even within a given muscle section (S4A Fig)
and we speculated this might correlate with fibre type or myofibre nuclear number. Alignment
of images with SDH-stained serial sections revealed a correlation between particle count and
SDH activity (i.e. oxidative fibres might express higher levels of dp427) however these regions
were also host to greater numbers of nuclei, and particle counts correlated better with total
nuclei than with SDH (S4B–S4D Fig), suggesting this is the principal source of within-section
variation. As normalizing counts to nuclei would bias against dystrophic muscle (infiltrating
non-muscle cells mean nuclear counts per field are significantly higher in this tissue: S4E Fig),
all analyses used non-normalized, per-image counts.
Fig 3. Dystrophin multiplex ISH in healthy mouse muscle. RNAscope ISH labelling of dp427 5’ and 3’ in 40-week
old WT quadriceps. Probe to dp427 5’ (Cy3: green) resolves both small sarcoplasmic foci and large nuclear foci, while
3’ probe (Cy5: magenta) shows small foci only. Foci are readily detected both in transverse (A) and longitudinal (B)
section. Scale bars: 100!m (main panel subdivisions: 20!m; magnified panel subdivisions: 10!m).
https://doi.org/10.1371/journal.pone.0239467.g003
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Despite marked differences in total count, healthy and dystrophic muscle exhibited similar
partitioning of apparent particle size (Fig 5B): signal from the 3’ probe was near-exclusively
comprised of foci 1–2!m2 in area while 5’ probe signal could instead be segregated into two
discrete populations, one of small foci similar to 3’ probe, and a second, larger and more het-
erogeneous population spanning 10–100!m2. We designated particles between 0.5–10!m2 as
‘small foci’ (95% of this population fell between 1–3!m2) and those 10–100!m2 as ‘large foci’.
As shown in Fig 5C and Table 1, counts of small foci were markedly lower in dystrophic mus-
cle, while counts of large 5’ foci were comparable between genotypes (60–100 per image,
accounting for 20–30% of total WT nuclei and, given the greater numbers of nuclei per field,
10–15% of mdx). Given the clear nucleus/sarcoplasm delineation within myofibres, we further
segregated foci by subcellular location (Fig 5D and 5E), confirming that large 5’ foci were
indeed restricted to nuclei (consistent with multiple nascent transcripts), while smaller foci of
both probes occupied nuclear and sarcoplasmic compartments (consistent with individual
completed transcripts). Crucially, counts of small nuclear foci were comparable between WT
and mdx: only the sarcoplasmic fractions of these small foci were reduced in dystrophic mus-
cle. The dp427 mRNA produced by mdx mice carries a premature termination codon (PTC)
in exon 23 [39] and is subject to nonsense-mediated decay (NMD) [40], but as this checkpoint
occurs after nuclear export [41], pre-export transcripts should remain.
Fig 4. Dystrophin multiplex ISH in dystrophic mouse muscle. RNAscope ISH labelling of dp427 5’ and 3’ in
40-week old mdx quadriceps muscle. Probe to dp427 5’ (Cy3: green) resolves large nuclear foci but numbers of small
foci are greatly reduced. 3’ probe (Cy5: magenta) reveals small foci only within or adjacent to nuclei. Nuclear foci are
readily detected both in transverse (A) and longitudinal (B) section. Rarely, nuclei with many 3’ foci not clearly
associated with 5’ nuclear foci are observed (Arrows, lower panels). As with positive and negative control probes,
apparently cell-restricted regions of non-specific staining are frequently observed (Arrowheads, middle panels), likely
corresponding to peroxidase-rich macrophage/neutrophil infiltration. Scale bars: 100!m (main panel subdivisions:
20!m; magnified panel subdivisions: 10!m).
https://doi.org/10.1371/journal.pone.0239467.g004
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5’ and 3’ probes co-localize and reveal mature dp427 mRNAs within
dystrophin positive revertant fibres
If mature dp427 transcripts can be dual-labelled, 5’ and 3’ signals should co-localize in healthy
muscle, but not dystrophic. WT muscle (Table 1, Fig 5C) exhibited a strong correlation
between counts of small 5’ and 3’ foci: on a per-image basis, Pearson correlations in this frac-
tion ranged from 0.91–0.97 (all P<0.0001), contrasted with 0.41–0.85 (P values from non-sig-
nificant to<0.0001) for mdx muscle (S5A and S5B Fig). As shown in Fig 6A, many
sarcoplasmic 5’ and 3’ foci appear to be in close apposition (arrowheads). We therefore mea-
sured 5’/3’ co-localization in these foci using a nearest-neighbour approach, determining mini-
mum distance between signals of opposing probes (as compared with the 3’ channel rotated,
or with equivalent numbers of randomly-distributed points, see Fig 6B). In healthy muscle
(Fig 6C, WT) almost 40% of all foci are paired within 1!m, whether 5’ to 3’ or the reverse,
something observed rarely (<1%) with equivalent numbers of randomly-distributed points
(indeed, all pairings below 4!m were over-represented in our analysis when compared with
random distributions -see S5C Fig). Analysis of the same images following 90˚ rotation of the
3’ channel was instead consistent with random distribution. In mdx muscle (with only ~100–
200 sarcoplasmic per image), many foci were more than more than 30!m from a focus of the
opposite probe: comparable with a random distribution or channel rotation. Sub-micron co-
localizations were however still observed, at levels approaching 25–30% of foci in some images
(Fig 6C, mdx). Again, such close association was not found with random distributions or chan-
nel rotation. Closer inspection showed these foci typically were found in small, fibre-restricted,
domains with sarcoplasmic 5’/3’ counts comparable to healthy muscle.
Fig 5. Particle analysis. (A) Total particle counts + SEM (N = 4 per genotype) for 5’ and 3’ probes in healthy (WT)
and dystrophic (mdx) muscle: values for each animal are shown. (B) Particle size distributions in WT and mdx muscle
as fraction of total (per image) particle number: brackets used to define small/large foci are shown. (C) Segregation by
small/large foci (as indicated) of total 5’ and 3’ signals, or signals after masking by nuclear stain (DAPI) to give nuclear
(D–all sarcoplasmic foci removed) or sarcoplasmic (E–all nuclear foci removed) counts. Note that large foci are found
only within nuclei, and only small sarcoplasmic foci (both 5’ and 3’) are significantly reduced in dystrophic muscle.
Representative image shown (same base image in all instances) is taken from a WT sample. Individual mean values per
animal are shown as dots ( : green = 5’; magenta = 3’) for all counts, or as dots (•) for size distributions. Each mean
represents the average of 9–30 images (same panel of images used for all analyses). ⇤ = P<0.05, Mann-Whitney U test.
Scale bar: 100!m (subdivisions: 10!m).
https://doi.org/10.1371/journal.pone.0239467.g005
Table 1. Mean per-image 5’ and 3’ particle counts for the eight quadriceps muscles examined.
5’ counts 3’ counts
Total Small Large Total Small Large
WT 1 1229 ±231 1145 ±221 84 ±14 1579 ±454 1571 ±446 8 ±9
WT 2 676 ±371 586 ±349 90 ±26 735 ±391 718 ±373 16 ±23
WT 3 641 ±282 559 ±265 82 ±21 806 ±319 789 ±302 17 ±19
WT 4 650 ±160 585 ±154 64 ±11 718 ±181 714 ±178 5 ±4
mdx 1 234 ±58 152 ±44 82 ±23 326 ±99 324 ±97 2 ±3
mdx 2 386 ±118 289 ±101 97 ±27 290 ±164 276 ±151 14 ±14
mdx 3 385 ±76 316 ±69 69 ±24 253 ±69 237 ±61 15 ±9
mdx 4 241 ±39 146 ±32 96 ±17 127 ±28 126 ±26 1 ±2
All measured particle counts, expressed as ‘total’ or subdivided by size (foci 0.5–10!m2 were classed as ‘small’, those >10!m2 as ‘large’). Values shown are
means ± standard deviations derived from 9–30 separate 20x images per muscle. Total and ‘small’ counts were significantly greater in WT muscle than dystrophic, while
‘large’ counts were not (P<0.05, Mann-Whitney U test). All mean values are shown graphically in Fig 5A and 5C.
https://doi.org/10.1371/journal.pone.0239467.t001
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We reasoned these foci might represent corrected dp427 transcripts expressed within spo-
radic dystrophin-positive revertant fibres [42], and as shown in Fig 7, these regions align with
revertants in serial sections immunolabelled for dystrophin protein. RNAscope images col-
lected only from regions aligning with revertant fibres (Fig 7D) showed higher mean sarco-
plasmic 5’ counts than images collected randomly, though the increase was not uniform: some
Fig 6. Co-localization of 5’ and 3’ signals. (A) 5’ and 3’ foci are found in close proximity. Images were masked to
restrict analysis to sarcoplasmic signals only. Foci closer than 1!m are indicated (small arrowheads) though isolated
foci of either probe were also observed (large arrowheads). Main panel scale bars: 100!m (subdivisions: 20!m);
magnified panel scale bars: 10!m (subdivisions: 2 !m). (B) Analysis parameters: distances between foci of 5’ and 3’
probe channels were examined for raw images, or the same images with the 3’ channel rotated by 90 degrees.
Representative image shown (same base image in all instances) is taken from a WT sample. A further set of analyses
were performed using virtual images with appropriate numbers of randomly distributed points. (C) Distribution of
distances between 5’ and 3’ sarcoplasmic foci. X-axis: distance between a given small 5’ sarcoplasmic signal and the
nearest 3’ (or vice versa) in microns, Y-axis: fraction of total foci paired within that distance for WT (upper panels) and
mdx (lower panels) quadriceps muscle. Left hand side: 5’-3’ distances are represented as green bars, 3’-5’ distances as
magenta (bars = means+SEMs, N = 4). ~40% of WT and ~15% of mdx foci co-localize within 1 micron while<1% of
WT and>30% of mdx foci are more than 30!m from a focus of the opposite probe. Right hand side: the same data
analysed after 3’ channel rotation. Overlaid traces represent expected mean distributions for 800 and 1200 random
points, or 200 and 400 random points (as indicated). With 200 or 400 random points,>30!m distances comprise 25%
and 5% of all pairings, while for 800 or more, typically<1% of points are paired at such distances.
https://doi.org/10.1371/journal.pone.0239467.g006
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regions of revertant fibres showed no concomitant increase in probe labelling, implying that
domains of dp427 mRNA might be more focal than those of dp427 protein.
Quantification of nascent and mature transcripts shows mature dp427
mRNA is short-lived
The necessity for separate fluorophores precludes direct comparison between 5’ and 3’ probe
fluorescence, but appropriate selection of exposure time (S6 Fig) renders small and large popu-
lations of 5’ probe foci quantitatively tractable. Fluorescence intensity values of small sarco-
plasmic foci are comparable between foci, images and individuals (Fig 8A, small foci): as these
Fig 7. dp427 expression in revertant fibres. Aligned serial sections of mdx muscle labelled with RNAscope ISH 5’/3’
probes (A) and IHC for dystrophin C-terminal antibody (B). RNAscope labelled regions corresponding to dystrophin-
positive revertant fibres show large numbers of sarcoplasmic 5’ and 3’ foci (C, 1st column) while those corresponding
to adjacent dystrophin-negative fibres do not (C, 2nd column). Note also presence of rare nuclei labelled with 3’ probe
alone in surrounding (non-revertant) tissue. (D) nuclear and sarcoplasmic counts of 5’ and 3’ foci from a single
RNAscope labelled dystrophic muscle using images collected at random or only from regions aligned with revertant
fibres as indicated: revertant images show increased numbers of small sarcoplasmic 5’ foci (Each dot represents a single
20x image, P<0.0001, Mann-Whitney U test). Scale bars: 100!m (main panel subdivisions: 20!m; magnified panel
subdivisions: 10!m).
https://doi.org/10.1371/journal.pone.0239467.g007
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represent single transcripts, comparing the mean single-transcript fluorescence intensity with
that of large myonuclear foci (Fig 8A, large foci) allows numbers of nascent nuclear dp427
molecules to be estimated. Our analysis suggests that in healthy muscle most myonuclei con-
tain 20–40 immature transcripts, though expression falls over a considerable range: rare nuclei
apparently have only 1–2 transcripts while others appear to contain 60 or more (some higher
values may reflect closely-apposed nuclei being counted together). Dystrophic myonuclei
exhibit a similar spread of values, but expression as a whole is markedly reduced, with mean
values suggesting only 10–12 nascent transcripts per nucleus.
This data, combined with the counts of mature dp427 mRNA molecules above, allows esti-
mation not only of total dystrophin expression, but also of the distribution of such expression
between mature mRNA molecules and transcripts in progress (Fig 8B). In dystrophic muscle
immature transcripts comprise the bulk of signal as would be expected, but even within
healthy muscle, prominent nuclear 5’ foci still represent ~10% of the total 5’ signals: with each
dp427-expressing nucleus host to 20–40 immature transcripts, the implication is that under
normal healthy conditions nascent transcripts account for 60–80% of total dp427 mRNA.
We corroborated these estimates by quantitative RT-PCR (qPCR) targeted to specific 5’ or
3’ regions of the dystrophin gene: using primers spanning the exon:exon junctions at 1–2, 44–
45 and 62–63, and quantifying absolute transcript numbers, we show that numbers of detected
transcripts do indeed decline as the target sequences approach the 3’ terminus, but in dystro-
phic muscle even 5’ signal is reduced, with transcripts containing exons 62–63 being reduced
yet further (to levels approaching zero). We also measured dp71 expression, showing this tran-
script is indeed present at low levels within skeletal muscle (see S8 Fig).
As shown (Fig 8C) qPCR-derived dp427 transcript numbers agreed closely with those obtained
via RNAscope both for healthy and dystrophic samples, and confirm that even in healthy muscle
the bulk of dp427 is immature. This marked ~3-4-fold bias toward incomplete transcripts, com-
bined with the estimated 16-hour transcription time for a single dp427 mRNA (see methods), sug-
gests that once completed and exported, a mature dystrophin transcript has an average lifespan of
only ~3.5 hours, substantially shorter than the time invested in its synthesis.
Fig 8. Nascent and mature dp427 transcripts. (A) Fluorescence intensity values from representative samplings of
well-focussed non-saturated foci from small sarcoplasmic and large nuclear 5’ probe populations. Values obtained
from three WT and three mdx mice (large foci only from mdx due to minimal numbers of small foci), using 3 images
(60–120 particles in total) per individual. As single transcripts, values for small foci fall over a relatively narrow range
and are moreover comparable between individuals (means±SD: WT1 6.0±2.7; WT2 8.4±3.5; WT3 6.1±2.7 AU) and
mean values can thus be used to estimate 5’ probe content of more heterogeneous large nuclear deposits (typically WT
100–400 AU; mdx 50–150 AU). AU = arbitrary units. (B) Estimated numbers of dp427 transcripts in healthy and
dystrophic mice by RNAscope counts: total transcripts (mean estimate of 5’ transcripts per nucleus multiplied by
number of large nuclear foci, plus all mature foci) vs mature transcripts only, per 20x imaging field (equivalent to ~1ng
RNA–see methods); (C) qPCR values: absolute transcript numbers per ng RNA as determined by qPCR to specific
dystrophin dp427m exons as indicated, compared against standard curves. Data normalized to the geometric mean of
APD3D1, ACTB, CNSK2A2 and RPL13a. All data shown as means + SEM (RNAscope N = 4, qPCR N = 9).
https://doi.org/10.1371/journal.pone.0239467.g008
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Single-transcript multiplex ISH permits quantification of dystrophin
induction via exon skipping
Finally, to investigate whether our ISH probes could detect rescued dp427 transcripts, we
examined dystrophic muscle treated with an exon-skipping agent. The mdx mouse carries a
PTC in exon 23 of dp427: this exon lies in-frame with those either side, and can thus be
‘skipped’ (omitted from the transcript during splicing): the resulting mRNA gives rise to inter-
nally-truncated but functional dystrophin protein. PIP6a PPMO molecules targeted to the
splice donor site of exon 23 have been used to induce high levels of dystrophin in the mdx
mouse: as shown previously [28], 10 doses of 12.5mg.kg-1 PPMO at 2-weekly intervals results
in widespread, uniform and high-level dystrophin protein expression (average ~50% of WT
levels, with individual animals ranging from 30–80%) while a lower dose (6mg.kg-1) results in
substantially lower expression (average ~15% of WT, with similar variability–D. Wells, manu-
script in preparation). Taking a single quadriceps muscle from each of these studies (high and
low dose), we visualized PPMO-mediated induction of dp427 mRNA using RNAscope probes.
As shown in Fig 9, the muscle treated with 6mg.kg-1 PPMO (where skipping levels are low)
appeared essentially indistinguishable from untreated mdx muscle, while muscle treated at
12.5mg.kg-1 (where skipping levels are high) exhibited robust numbers of sarcoplasmic 5’ and
3’ foci. Particle analysis suggested these numbers were comparable to WT, and moreover
showed 5’-3’ co-localization not seen with lower dose treatment (S7A and S7B Fig). In this
high dose treated muscle, the fraction of nuclei with large 5’ foci was also restored to WT levels
(25–30%) and nuclear 5’ signal was similarly more intense, yet numbers of nuclei per field
remained elevated (comparable with untreated mdx, see S7C Fig), with the corollary that all
nuclear counts (5’ and 3’) were higher than those of WT muscle (i.e. implying supra-phyisolo-
gical levels of nascent transcription within this muscle).
Discussion
Resolution of mRNA molecules by in-situ hybridization has historically faced a number of chal-
lenges: abundant mRNAs can be detected relatively easily (indeed ISH using fluorescent probes
(FISH) works well with such transcripts), but useful quantitative and spatial expression data is
often lost in the consequent wash of strong signal. Conversely, low abundance transcripts (such
as dystrophin) might well lend themselves to more nuanced analysis, but cannot usually be
detected with significant confidence to allow such analyses. Most high-sensitivity ISH methods
are either radiometric or colorimetric, and thus cannot easily be multiplexed. The RNAscope
in-situ fluorescence amplification approach offers high sensitivity and multiplexing [24]: though
typically used to resolve multiple mRNA species within a tissue, we show this ISH method can
visualize multiple regions within a single transcript. The enormous genomic dystrophin (DMD)
locus (~2.3Mbp, with 16-hour transcription time) further allows temporal metrics to be
assessed, as nascent transcripts label with 5’ probe only. Our work demonstrates a multiplex
method that is particularly suited to long mRNAs transcribed from large genomic loci, allowing
the identification of transcriptional subtleties that would otherwise remain intractable. Given
that the dystrophin gene has key disease-relevance with many therapeutic approaches directed
at the transcript level, our approach is particularly suited to its study.
Subcellular localization of mature dp427 mRNA
We show that individual mature dp427 mRNAs can be detected within the muscle sarcoplasm,
binding 5’ and 3’ probes in close proximity as expected. These mature transcripts are essen-
tially absent in dystrophic muscle, yet comparatively high numbers (binding both probes) are
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found in rare patches that align with dystrophin immunoreactive revertant fibres. Previous in-situ
studies of dp427 expression suggested that this transcript preferentially localizes to the sarco-
lemma [17]. Given the sarcolemmal location of the dystrophin protein, this seems biologically
plausible. A single mRNA is relatively compact and can give rise to multiple protein molecules:
targeting dp427 mRNA to the sarcolemma before translation would be more efficient than trans-
porting protein post-translationally. Our data supports this: while in both longitudinal and trans-
verse orientations mature dp427 molecules are clearly found throughout the myofiber interior,
transcript concentration does appear to be highest immediately beneath the sarcolemma.
Fig 9. RNAscope detection of dp427 restoration following PPMO exon skipping. RNAscope probes to dp427 5’
(Cy3: green) and 3’ (Cy5: magenta) in WT and mdx quadriceps muscle, or mdx muscle treated with PIP6a PPMO at
6mg.kg-1 or 12.5mg.kg-1 as indicated (note clear expression of nascent dp427 within centrally-located nuclei, mdx
inset). High doses of PPMO restore sarcoplasmic probe labelling. Scale bars: 100!m (main panel subdivisions: 20!m;
magnified panel subdivisions: 10!m).
https://doi.org/10.1371/journal.pone.0239467.g009
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Behaviour and quantification of mature dp427 mRNA
Under physiological conditions, most messenger RNA is expected to exhibit extensive second-
ary structure, and to be found as mRNP complexes with RNA binding proteins [43]. This is
especially true for mRNA molecules with large 5’ and 3’ UTRs (such as dp427): the 5’ and 3’
termini of such mRNAs are reported to be very closely apposed in most cases (potentially in
the order of nanometre separations [44]). Efficient probe hybridization however necessitates
unfolding of mRNP complexes and mRNA secondary structure, potentially disrupting this co-
localization. In healthy muscle labelled with our dystrophin probes, ~40% of sarcoplasmic 5’
signals were nevertheless found within a micron of a 3’ signal (and vice-versa), strongly sug-
gesting that many transcripts remain close to their native configuration (and that the physio-
logical state of a mature dp427 mRNA is indeed a condensed complex with 5’ and 3’ ends in
close proximity). Remaining pair distances were also shorter than would be expected by
chance, raising the possibility that some might represent labelling of unfolded transcripts.
Length per base of single-stranded RNA remains contentious [45], and may vary with salt con-
centration and pH [46], thus we cannot empirically state the maximum permissible separation
of probes within a single dp427 mRNA. Using reported values for ssDNA (~0.7nm per base
[47]) would place the length of a mature full-length dystrophin transcript at ~10!m, with 5’
and 3’ probe binding sites separated by ~6!m (though ssRNA also adopts flexible, worm-like
chain behaviour: mean 5’-3’ distance would be substantially shorter [48]). The size and mobil-
ity of the amplifier ‘trees’ generated by RNAscope ISH is not reported, and deposits of fluoro-
phore (activated tyramides react with tyrosine residues in adjacent proteins) might also extend
beyond these limits, but restricting probe pairings to distances <6!m would account for ~70%
of the observed foci in WT muscle (~80% with a more generous 8!m). Some foci will inevita-
bly lie sufficiently out of focus as to be missed by particle analysis, and some dp427 transcripts
will likely label with one probe but not the other (due to inhibitory secondary structure, mask-
ing by protein, or even cleavage of the molecule during sectioning): our mature mRNA counts
might thus be an underestimate of true numbers, though our corroborating qPCR data sug-
gests any underestimate is modest. Interestingly, counts of 3’ foci were typically higher than 5’,
by a small but consistent amount (50–100). The consistent size and intensity of 3’ foci allows
this signal to be collected with greater ease than 5’ (where overexposure of the strong nuclear
foci must be balanced against underexposure of the weaker sarcoplasmic foci, and 5’ foci in
mature dp427 molecules close to nuclei may be lost amidst strong nascent 5’ staining), how-
ever 3’ foci without adjacent 5’ might also represent labelling of dp71 [26]. While not reported
to be expressed in muscle fibres specifically, this isoform is expressed in blood vessel endothe-
lia [49] and proliferating myoblasts [50], and is detected at low levels within whole muscle tis-
sue homogenates, particularly those from young dystrophic muscle undergoing acute
degeneration/regeneration [51]. qPCR confirms dp71 is modestly expressed in both healthy
and dystrophic quadriceps muscle (in numbers that might account for ~50–70 additional 3’
foci per 20x image: see S8 Fig) but ISH also places this modest expression in context: dp71 is
robustly expressed, but apparently restricted to a small number of specific cells, potentially
only visible in dystrophic muscle where levels of dp427 are lower (see Fig 4B, lower panels).
Endothelia are a plausible candidate, but combining dp427 multiplex ISH with cell-specific
markers (such as PECAM) will be necessary to confirm this.
Behaviour and quantification of nascent dp427 mRNA
The strong 5’ probe signal within dp427-expressing nuclei is consistent with concerted expres-
sion (Smith et al reported similar findings in the nuclei of cultured myotubes using conven-
tional fluorescent probes [25]: while unable to resolve single transcripts, they reliably resolved
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the prominent nuclear dp427 transcriptional locus). This strong, unambiguous 5’ nuclear
labelling permits estimation of myonuclear number, a value otherwise difficult to determine.
Muscle is host to multiple cell types, from blood-vessel endothelia and pericytes/mesoangio-
blasts to fibroblasts, adipocytes, and the dedicated muscle stem cell population of satellite cells
[19, 20], but only myonuclei should robustly express full-length dystrophin and thus label
strongly with 5’ probe. Our ISH data indicates 20–30% of the nuclei within a typical non-
tendinous region of healthy quadriceps muscle express dp427, while in dystrophic muscle this
fraction is only 10–15% (despite similar absolute numbers of large 5’ foci: see Table 1), com-
mensurate with the higher fraction of non-myonuclear cell types within the dystrophic muscle
environment. We also calculate that healthy dystrophin-expressing nuclei are typically host to
20–40 immature transcripts: if this represents steady-state occupancy, it implies active myonu-
clei produce one dp427 transcript every 20–30 minutes (though ~5 hours are required to tran-
scribe the full 5’ binding sequence, thus true nascent counts may be ~30% higher). Both ISH
and qPCR data also suggest that mature dp427 mRNAs are in the clear minority: 60–80% of
dp427 transcripts within healthy skeletal muscle are nascent, presumably arrayed along the
dystrophin genomic locus (Fig 10A). The surprising corollary is that mature dp427 transcripts,
despite taking 16 hours to produce, have half-lives of only ~2–3 hours (mean lifetime of 3–4
hours). Similar results were first reported in the late 90s by Tennyson and colleagues [16]
Fig 10. Dystrophin transcriptional dynamics revealed by single-transcript multiplex ISH. In WT muscle
myonuclei (A), multiple transcriptional initiation events occur during the 16 hours needed for a single transcript to
complete, resulting in a steady ‘train’ of RNA polymerases and nascent transcripts, and leading to high nuclear
concentrations of dp427 5’ sequence. Dp427 3’ sequence is completed only ~15 minutes before transcript completion
and export, thus is present at much lower levels within the nucleus. Mature dp427 mRNAs, validated by the pioneer
round of translation and carrying both 5’ and 3’ sequence, are found distributed throughout the sarcoplasm but are
then degraded. In mdx muscle myonuclei (B), transcriptional initiation events are less frequent, leading to fewer
nascent 5’ sequences within nuclei, and the presence of a PTC (red crosses) within the dp427 transcript leads to
prompt post-export mRNA degradation via the NMD pathway.
https://doi.org/10.1371/journal.pone.0239467.g010
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using radiolabelled RT-PCR on samples of human skeletal muscle, and the values they
obtained were remarkably close to those shown here: mean 5’ and 3’ totals were ~2500 and
~780 per ng RNA respectively (interestingly, with sample-to-sample variation similar to that
found in our study), with concomitant derived half-life of ~3.5 hours. This early finding has
garnered little mention since -even the authors themselves treated this result with scepticism-
but our work here (showing similar values in a different species) strongly supports this
remarkable conclusion. Tennyson et al reported a markedly longer half-life of ~16 hours in
cultured human foetal myotubes: this discrepancy was attributed to either differential turnover
rates between cultured myotubes and mature muscle, a higher rate of premature termination
in mature muscle, or an indication that mature skeletal muscle was not at transcriptional
steady-state (samples were collected from human cadavers). Our data, obtained from adult
mouse muscle flash-frozen 2–5 minutes post-mortem, would argue against this latter hypothe-
sis. Relatively high rates of premature termination are certainly plausible: at 2.3 million bases,
the dystrophin gene likely tests the limits of RNA polymerase processivity [52], and some evi-
dence exists for premature termination rates above predicted values [21], but such limits are a
function of length, not maturity. It is thus unclear why rates would differ markedly between
myogenic cultures and mature muscle. Dp427 may simply experience a higher rate of turnover
in mature muscle: the demand for dystrophin is likely to be higher in nascent myotubes where
the contractile environment is being established de novo (whereas turnover of an existing dys-
trophin protein pool may be all that is required in mature tissue). Production of dystrophin
transcripts could be considered innately wasteful (synthesis of a 2.3Mb pre-mRNA for a final
spliced transcript of only 14kb), but it nevertheless seems counterintuitive that mature muscle
myonuclei dedicate 16 hours to producing a molecule with a mean subsequent lifespan of only
4. Dp427 transcripts comprise only a tiny fraction of myonuclear mRNAs (several thousand-
fold lower than myosin heavy chain mRNA [16]) thus such waste is likely of little energetic
consequence, and post-transcriptional control via mRNA stability in fact offers markedly
greater utility than control of transcription itself: changes in expression based on transcrip-
tional initiation would necessarily incur at least a 16-hour delay (and another 16-hour delay to
return to basal levels) and this presumes the dystrophin locus is not already at near-maximal
transcriptional occupancy. In contrast, changes in mRNA stability can be achieved rapidly via
phosphorylation [53], and simply halting degradation of mature dp427 transcripts (leaving
transcription unchanged) would double mRNA levels in less than half that time: constitutive
overproduction paired with tuneable degradation is wasteful, but responsive. This mechanism
might even be common among large genes: the human genome is host to a number of genes
larger than 1Mb (>7 hour transcription times), many of which may need to alter expression
over shorter timescales. Dynamic expression of dp427 would readily explain the high sample-
to-sample variation reported here and previously [16], and control via mRNA stability would
allow expression to fluctuate over a circadian timescale (as has been suggested [54]). It would
be of great interest to examine the behaviour of our RNAscope probes in damaged (Cardio-
toxin or BaCl2-treated), regenerating healthy muscle: if stability of transcripts is higher in
nascent myotubes, one might expect newly regenerated fibres to exhibit markedly higher levels
of mature dp427 mRNA (something suggested by early ISH work [18]).
Tennyson et al derived estimates of 5–10 nascent dystrophin mRNAs per muscle nucleus
[16]. Our data refines this estimate: not all nuclei within a muscle express dp427 (see above),
but those that do are host to 20–40 nascent transcripts at a time. This argues in favour of a con-
certed commitment to dystrophin expression and provides further support for a maximized
production hypothesis. Rare nuclei nevertheless appear to have lower (2–10) numbers of
transcripts, suggesting that dystrophin-expressing nuclei might not all be at steady-state
expression levels at any given moment: we cannot rule out a sustained but ‘burst-like’
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stochastic expression programme as is common to many eukaryotic genes [55] (and indeed tran-
scription in muscle has been reported to exhibit ‘pulsed’ behaviour [56]). Transcriptional bursting
could result in ‘quiescent’ myonuclei that do not label with 5’ probe (leading to underestimation
of myonuclear fraction). Expression of dp427 represents an implicit 16-hour commitment, how-
ever, and counts of dp427-expressing nuclei were moreover remarkably consistent between ani-
mals (Table 1 and Fig 5D), suggesting any underestimation is likely to be modest.
Dystrophic muscle reveals further nuances: while numbers of mature transcripts are
reduced to almost zero as expected, the intensity of 5’ probe labelling within myonuclei is also
reduced. This reduction in total message is confirmed via qPCR. This latter observation could
be dismissed as a reflection of the higher cell content and transcriptional diversity within dys-
trophic muscle (thus fewer total myonuclei), but our ISH data shows that this reduction in
expression extends to the myonuclei themselves. Transcript degradation via NMD occurs only
after transcription is complete [41], thus reduction in nuclear signal is best explained by a
lower rate of transcriptional initiation (10–12 nascent transcripts per nucleus, thus one tran-
script initiated/completed every 60–90 minutes). It has been proposed that as a terminal
marker of myogenesis, expression of dystrophin itself drives the myogenic programme to com-
pletion: low levels of dystrophin expressed earlier in differentiation help drive greater expres-
sion of dystrophin, further promoting terminal differentiation and producing a switch-like
feed-forward loop [57, 58]. Dystrophic muscle, lacking this driver of terminal myofiber com-
mitment, would thus be held in a permanent state of near-maturation, with concomitantly
lower levels of dystrophin transcription and reduced 5’ nuclear staining intensity (Fig 10B).
Our dp427 probes also detected transcripts within revertant fibres: these sporadic dystro-
phin-positive fibres are a long-recognized phenomenon [42, 59, 60], and are variably
explained. Prevalence of revertants is influenced by the specific mutation carried (the PTC in
exon 23 of the mdx mouse readily lends itself to revertant fibre formation, while the PTC in
exon 53 of the mdx4cv mouse does not [61]), and revertant fibre number also tends to increase
with age, clustering in a fashion that implies a clonal origin [62, 63] (skipped transcripts are
found even in healthy muscle [64]). Current hypotheses tend to favour a coordinated, focally
heritable alteration in splicing patterns rather than mutations at the genomic level [62]: our
approach cannot distinguish these two proposals (and strong 5’ labelling of all nascent mRNAs
makes assignation of revertant expression to a specific nucleus or nuclei essentially impossi-
ble), but our data suggest that revertant fibres exhibit high (near-WT) levels of mature dp427
within relatively restricted domains, as might be expected if transcripts are short-lived. We
also show ISH can detect corrected transcripts following therapeutic exon skipping, revealing
spatial metrics that complement conventional assessments. While we examined only two mus-
cles (one from a high dose treatment group, one from low dose), the muscle treated with a low
dose of skipping oligonucleotide giving only 2–10% skipping efficiency (D. Wells, manuscript
in preparation) was indistinguishable from untreated mdx, while the high dose treated muscle
(which produces skipping efficiencies of 30–60% [28], and uniform sarcolemmal dystrophin
protein) showed sarcoplasmic dp427 mRNA counts comparable to those of WT muscle. This
data is only proof of principle (and the expense of this technique likely limits widespread diag-
nostic utility), but it illustrates potential limitations in measuring skipping percentages via
qPCR alone, especially for an exon nearer the 5’ end of the dp427 transcript (such as exon 23):
values expressed as a ratio do not give absolute numbers, and while skipped transcripts will
give rise to mature dp427 mRNAs (unlike unskipped, which will be degraded), even in healthy
muscle, mature mRNA represents only ~20% of total dp427; the majority of the dp427 mea-
sured via qPCR (skipped or unskipped) will be nascent rather than mature transcripts. ISH
conversely allows direct visualisation and quantification of mature transcripts (and estimation
of total transcript numbers), but does not permit assessment of skipping percentages. This
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preliminary data further suggests multiplex ISH might reveal changes in transcriptional
dynamics following treatment: total nuclei per field in the 12.5mg.kg-1 PPMO (high dose)
treated muscle were higher than WT (comparable to untreated mdx) but the fraction of nuclei
expressing dp427 was comparable to healthy muscle (i.e. total numbers of dystrophin-express-
ing nuclei were higher than WT); even without 100% skipping efficiency, treated muscles
might achieve physiological levels of mature dp427 by producing supra-physiological levels of
nascent transcripts. Questions remain, however: skipped transcripts are typically detectable
within a week of systemic treatment, but a study following long-term response to exon skip-
ping treatment in the mdx mouse [65] reported a 2–3 week lag between first detection of
skipped transcripts and restoration of dystrophin protein, and further showed that both
skipped dp427 transcripts and particularly dystrophin protein itself persisted for some weeks
following the cessation of treatment. Levels of skipped transcripts and dystrophin protein in
this study were low (~10% and 1–3% of WT respectively) but these data nevertheless suggest
that the mean lifespan of dystrophin protein is of the order of days to weeks, and moreover
that protein turnover is comparatively slow. It is hard to reconcile this with the mRNA dynam-
ics revealed by our studies here (and those reported historically [16]): despite a lengthy tran-
scription time, mRNA turnover of dp427 appears to be remarkably rapid. Tissue persistence of
antisense oligonucleotides was found to decline in line with falling skipping percentages [65],
compatible with ongoing skipping of short-lived dp427 mRNAs, but the high stability of the
dystrophin protein and the fact that this protein represents only a relatively minor component
of the muscle protein milieu [14] seems incompatible with such dynamic transcript behaviour.
The implication is that in healthy muscle, dp427 mRNA molecules may be actively degraded
despite having contributed essentially no dystrophin protein beyond the first post-export pio-
neering ribosomal proof-read: at the mRNA level, supply might substantially exceed demand.
If correct, this surprising finding might be of considerable value to therapeutic approaches for
DMD such as gene editing: if under healthy conditions many more transcripts are produced
than are needed, in dystrophic conditions beneficial levels of dystrophin protein might be
restored with only modest levels of genomic correction (and studies suggest this may be the
case [66–70]).
Concluding remarks
The work shown here validates a novel, spatiotemporal use of RNAscope methodology, dem-
onstrating the value of multiplex targeting within a single transcript, particularly with mRNAs
transcribed from long genomic loci such as the dystrophin gene. In this study we focus on
mature mouse skeletal muscle, a tissue within which dystrophin expression is almost exclu-
sively dp427. Single transcript multiplex ISH (5’ and 3’) reveals dystrophin transcriptional
dynamics, showing that even in healthy muscle most dp427 is nascent, and that mature tran-
scripts are remarkably short-lived (a conclusion supported by qPCR). Subcellular resolution of
individual transcripts -and moreover discrete regions of those transcripts- has wider applica-
tions. Use of a third ‘middle’ probe alongside the 5’ and 3’ probe sets described here allows the
full-length dp427 isoform to be distinguished from dp260/dp140, and in turn from dp116/
dp71: we have used this ISH method to study expression of dystrophin isoforms during
embryonic development [26], something historically precluded by shared sequence identity at
both protein and mRNA level. A logical target for further investigations would be the brain, a
complex tissue known to express a similarly complex combination of dystrophin isoforms: our
ISH approach would allow these isoforms to be mapped to subcellular levels and might allow
us to determine whether brain dp427 isoforms (dp427c, dp427p) are as short-lived as dp427m.
Indeed, while the current therapeutic focus is on skeletal muscle, the brain is also known to be
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affected by dystrophin mutations: if treatment of skeletal muscle continues along current
encouraging lines, the brain might be the next major therapeutic target, and the in situ hybrid-
ization methodology described here offers a powerful tool to aid such investigations.
Supporting information
S1 Fig. Fresh-frozen muscle does not tolerate the detergent incubations used in the RNA-
scope hybridization/washing stages without additional fixation and baking. Serial slides
were treated according to the protocol for fresh-frozen tissue, with a single slide taken at each
indicated step and stained via Haematoxylin and Eosin. Protease treatments are well-tolerated,
but muscle is visibly paler after probe incubation (lower left) and all myofibrillar material is
lost entirely after a single subsequent wash.
(TIF)
S2 Fig. Positive and negative control probes. Positive control probes (Polr2a, Ppib, UBC -upper
panels): Both WT (A) and mdx (B) muscle show the expected pattern: rare foci are observed for
probes to Polr2a (very low abundance transcript in muscle), Ppib (low abundance in muscle) pro-
duces more foci, and staining for UBC (high abundance) is widespread. All transcripts appear to
be more plentiful immediately beneath the muscle sarcolemma. Dystrophic muscle also shows
patches of prominent non-specific staining (particularly in FITC and Cy3 channels) which may
correspond to peroxidase-rich macrophage/neutrophil infiltrates (arrowheads). Negative control
probes (bacterial DapB): WT muscle (C) shows no staining in any of the negative control probe
channels. Dystrophic muscle (D) shows no probe-specific foci, but as with positive control stain-
ing (above), this tissue exhibits patches of prominent non-specific staining (particularly in FITC
and Cy3 channels) which may correspond to macrophage/neutrophil infiltrates (arrowheads).
Scale bars: 100!m (main panel subdivisions: 20!m; magnified panel subdivisions: 10!m).
(TIF)
S3 Fig. RNAscope labelling of dp427 5’ and 3’ with reversed fluorophores. RNAscope probe
labelling of 40-week old WT and mdx quadriceps muscle. Probe to dp427 5’ (Cy5: magenta)
resolves both small sarcoplasmic foci and large nuclear foci, while 3’ probe (Cy3: green) shows
small foci only, showing that this pattern is a property of the probes, not the fluorophores
selected. Scale bars: 100!m (main panel subdivisions: 20!m; magnified panel subdivisions:
10!m).
(TIF)
S4 Fig. Foci per image correlates with oxidative capacity and nuclear count. (A) total 5’ and
3’ counts per image, per individual (9–30 images per animal). (B) Alignment of RNAscope
images collected with oxidative capacity: DAPI channel of RNAscope-probed WT muscle with
locations of images indicated (left) and matching approximate locations in an SDH-stained
serial section (right). Strongly SDH-stained regions (1) have more foci, but also more nuclei
than regions of less oxidative fibres (2). SDH intensity correlates with total foci count but does
not reach significance (C), while total foci count and number of nuclei per field show greater
correlation (D). Images collected from mdx sections have significantly higher numbers of
nuclei per field (E). Correlations: Spearman’s rho. Nuclear counts: Mann-Whitney U test
using mean per image nuclear counts, per animal (N = 4 per genotype).
(TIF)
S5 Fig. Numbers of small 5’ and 3’ foci per image show strong correlation in WT muscle,
but not necessarily in dystrophic muscle. (A) Representative plot of 5’ counts vs 3’ counts for
1 healthy and 1 dystrophic individual. (B) Correlations per individual for both small foci and
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total foci (top rows: Pearson r values; Bottom rows: significance. ⇤ = P<0.05;⇤⇤ = P<0.005;⇤⇤⇤
= P<0.0005;⇤⇤⇤⇤ = P<0.0001; N/S = not significant). (C) Distributions of nearest-neighbour
distances greater than 1!m in images from WT (left) and mdx (right) muscle, compared with
random distributions of the appropriate number of points (WT: 800, 1200; mdx: 200, 400) or
from the same images after 3’ channel rotation. Distances <4!m are over-represented in both
WT and mdx muscle.
(TIF)
S6 Fig. Large and small 5’ foci can be quantitatively compared. Left columns: Images of 5’
foci only were collected at 100, 200, 400, 600 and 800ms exposure times and the highest expo-
sure images were used to define regions of interest (large foci, small foci, background). Mean
fluorescence intensity in each ROI was determined for each exposure time and plotted (right).
Background and small foci fluorescence values increase linearly with exposure time, whereas
large foci show attenuation above 200msec, showing signal saturation. All comparisons thus
used 100 and 200msec values. Images shown is cropped for clarity: all analysis used full size
images with 30–50 foci of each class defined per image, using 3–5 images per individual.
(TIF)
S7 Fig. Additional exon-skipping analyses. (A) Numbers and distributions of 5’ and 3’ foci in
PPMO treated muscles. WT and untreated mdx values are from Fig 5. Treatment with 12.5mg.
kg-1 restores small sarcoplasmic dystrophin counts to near-WT levels but also increases total
nuclear counts of all foci. (B) PIP6a PMO treatment at 6mg.kg-1 does not restore probe co-
localization whereas treatment at 12.5mg.kg-1 does. (C) PIP6a PPMO-treated muscles still
exhibit per-image nuclear counts comparable to untreated mdx muscle.
(TIF)
S8 Fig. Expression of dp71 in skeletal muscle. Absolute quantification of transcript numbers
in WT and mdx quadriceps muscle using primers to exons 62–63 of dp427 (mature dp427) or
to exons 1–2 of dystrophin isoform dp71 (dp71 unique first exon, and exon 63 of dp427).
Dp71 is expressed in muscle but at low levels (50–70 transcripts per ng RNA) and is not altered
in response to dystrophic pathology. Numbers of dp71 transcripts are however comparable
with the greatly reduced numbers of mature dp427 transcripts in mdx muscle.
(TIF)
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